CLINICAL_TRIALS
research
· 2009-05-27
Clinical Trial Update: The Role of Angiopoietin, Tie-2, and Vascular Endothelial Growth Factor (VEGF) in Sepsis-Induced Multiple Organ Dysfunction Syndrome (MODS)
Summary
This document discusses the roles of angiopoietin, Tie-2, and VEGF in sepsis-induced multiple organ dysfunction syndrome and references a clinical trial (NCT009…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Chang Gung Memorial Hospital | Conditions: Sepsis, Multiple Organ Dysfunction Syndrome | Status: UNKNOWN